CS
CLLS

Credit Suisse’s Cellectis CLLS Stock Holding History

Credit Suisse’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$3.81M Hold
1,438,255
– – ﹤0.01% 1455
2023
Q4 		$4.43M Hold
1,438,255
– – ﹤0.01% 1403
2023
Q3 		$2.27M Hold
1,438,255
– – ﹤0.01% 1747
2023
Q2 		$2.83M Hold
1,438,255
– – ﹤0.01% 1692
2023
Q1 		$2.78M Hold
1,438,255
– – ﹤0.01% 1679
2022
Q4 		$3.02M Hold
1,438,255
– – ﹤0.01% 1640
2022
Q3 		$3.29M Hold
1,438,255
– – ﹤0.01% 1514
2022
Q2 		$4.07M Sell
1,438,255
-3,330
-0.2% -$11.7K ﹤0.01% 1428
2022
Q1 		$6.54M Buy
1,441,585
+238,284
+20% +$1.31M 0.01% 1288
2021
Q4 		$9.77M Buy
1,203,301
+3,301
+0.3% +$32.4K 0.01% 1516
2021
Q3 		$15.1M Sell
1,200,000
-1
-0% -$14 0.01% 1250
2021
Q2 		$18.6M Sell
1,200,001
-356
-0% -$5.99K 0.01% 1177
2021
Q1 		$24.3M Sell
1,200,357
-10
-0% -$247 0.01% 1060
2020
Q4 		$32.5M Buy
1,200,367
+500,367
+71% +$11.2M 0.02% 910
2020
Q3 		$12.9M Hold
700,000
– – 0.01% 1235
2020
Q2 		$12.5M Buy
700,000
+239,971
+52% +$3.65M 0.01% 1191
2020
Q1 		$4.23M Sell
460,029
-4,794
-1% -$71.5K ﹤0.01% 1646
2019
Q4 		$7.96M Buy
464,823
+4,814
+1% +$64.3K 0.01% 1548
2019
Q3 		$4.78M Sell
460,009
-260
-0.1% -$3.5K ﹤0.01% 1796
2019
Q2 		$7.18M Buy
460,269
+129
+0% +$2.3K 0.01% 1516
2019
Q1 		$8.44M Sell
460,140
-165
-0% -$2.92K 0.01% 1340
2018
Q4 		$7.66M Buy
460,305
+39,638
+9% +$919K 0.01% 1307
2018
Q3 		$11.9M Buy
420,667
+35,363
+9% +$1.02M 0.01% 1161
2018
Q2 		$10.9M Sell
385,304
-65,194
-14% -$1.94M 0.01% 1186
2018
Q1 		$14.2M Buy
450,498
+160,581
+55% +$5.07M 0.01% 1042
2017
Q4 		$8.45M Buy
289,917
+149,917
+107% +$4.08M 0.01% 1399
2017
Q3 		$3.98M Buy
140,000
+80,000
+133% +$2.07M ﹤0.01% 1948
2017
Q2 		$1.55M Buy
+60,000
New +$1.43M ﹤0.01% 2400
2015
Q4 		– Sell
-8,170
Closed -$215K – 4220
2015
Q3 		$215K Buy
+8,170
New +$273K ﹤0.01% 3895

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Credit Suisse's CLLS Position: Q1 2024 in Review

Credit Suisse held its Cellectis (CLLS) position steady in Q1 2024 at 1,438,255 shares worth $3.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1455.

Credit Suisse first reported a position in CLLS in Q3 2015 and has held it in 29 quarters since. The position peaked at $32.5M in Q4 2020. 31 funds tracked by Wall St. Rank hold CLLS as of Q1 2024.

  • Credit Suisse held 1,438,255 shares of Cellectis worth $3.81M as of Q1 2024.
  • Credit Suisse left its Cellectis share count unchanged in Q1 2024.
  • Cellectis made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1455 holding.
  • Credit Suisse first reported a position in Cellectis in Q3 2015 and has held it in 29 quarters since.
  • Credit Suisse's Cellectis position peaked at $32.5M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Cellectis as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.